CD8A and cancer: Furthermore, this observation has immunological implications as TAA-presenting DC engage with and activate CD4+ and CD8+ TAA-specific T cells within the paracortex [48, 49] as we demonstrated in a prior BMDC-based cancer vaccine study [26].